Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-an
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1
![Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER - European Journal of Cancer Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER - European Journal of Cancer](https://www.ejcancer.com/cms/asset/6e348d9e-fe9b-4434-bcdd-024b6b770d67/gr1.jpg)